Cargando…

Pharmacokinetic Study of Oral (14)C-Radiolabeled Hyzetimibe, A New Cholesterol Absorption Inhibitor

Background and objectives: Hyzetimibe is a candidate drug being investigated as the second-in-class cholesterol absorption inhibitor; it lowers plasma levels of low-density lipoprotein cholesterol (LDL-C) by blocking the Niemann-Pick C1-like 1 protein, a transporter mainly expressed in the intestine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Jianwei, Wang, Xin, Li, Zhenyu, Ouyang, Dongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194275/ https://www.ncbi.nlm.nih.gov/pubmed/34122085 http://dx.doi.org/10.3389/fphar.2021.665372

Ejemplares similares

The NPC1L1 Gene Exerts a Notable Impact on the Reduction of Low-Density Lipoprotein Cholesterol in Response to Hyzetimibe: A Factorial-Designed Clinical Trial
por: Liao, Jianwei, et al.
Publicado: (2022)

Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers
por: Chen, Lulu, et al.
Publicado: (2018)

Pharmacokinetics, absorption, distribution, metabolism and excretion of the MEK inhibitor zapnometinib in rats
por: Füll, Yvonne, et al.
Publicado: (2022)

Pharmacokinetics and absorption mechanism of tandospirone citrate
por: Li, Rong, et al.
Publicado: (2023)

Food and Sex-Related Impacts on the Pharmacokinetics of a Single-Dose of Ginsenoside Compound K in Healthy Subjects
por: Chen, Lulu, et al.
Publicado: (2017)

CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population
por: Huang, Xinyi, et al.
Publicado: (2021)

Pharmacokinetics, Distribution, Metabolism, and Excretion of Omadacycline following a Single Intravenous or Oral Dose of (14)C-Omadacycline in Rats
por: Lin, Wen, et al.
Publicado: (2016)

Physiologically Based Pharmacokinetic Modeling to Understand the Absorption of Risperidone Orodispersible Film
por: Chen, Fang, et al.
Publicado: (2020)

Absorption, Metabolism, and Excretion of [(14)C]-Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Male Subjects
por: Gupta, Vipul K., et al.
Publicado: (2023)

Cholesterol Stimulates the Transient Receptor Potential Melastatin 4 Channel in mpkCCD(c14) Cells
por: Cai, Yong-Xu, et al.
Publicado: (2021)

Baicalin Enhanced Oral Bioavailability of Sorafenib in Rats by Inducing Intestine Absorption
por: Wei, Jingyao, et al.
Publicado: (2021)

Maternal and Fetal Pharmacokinetics of Oral Radiolabeled and Authentic Bisphenol A in the Rhesus Monkey
por: VandeVoort, Catherine A., et al.
Publicado: (2016)

Clinical Validation of a Volumetric Absorptive Micro-Sampling Device for Pharmacokinetic Studies With Tranexamic Acid
por: Grassin-Delyle, Stanislas, et al.
Publicado: (2021)

Radiolabeled PSMA Inhibitors
por: Neels, Oliver C., et al.
Publicado: (2021)

Rapid absorption of diclofenac and acetaminophen after their oral administration to cattle
por: SAWAGUCHI, Akiyo, et al.
Publicado: (2016)

Phase I pharmacokinetic study of an oral, small-molecule MEK inhibitor tunlametinib in patients with advanced NRAS mutant melanoma
por: Zhao, Qian, et al.
Publicado: (2022)

Radiolabeling of Cramoll 1,4: Evaluation of the Biodistribution
por: Ferreira de Carvalho Patricio, Beatriz, et al.
Publicado: (2011)

Pharmacokinetic Imaging with Radiolabeled Molecularly Targeted Anticancer Drugs
por: Bauer, Martin, et al.
Publicado: (2020)

Pharmacokinetic evaluation of radiolabeled intraocular anti‐CLEC14a antibody in preclinical animal species and application in humans
por: Park, Sohyun, et al.
Publicado: (2022)

SHR2285, the first selectively oral FXIa inhibitor in China: Safety, tolerability, pharmacokinetics and pharmacodynamics combined with aspirin, clopidogrel or ticagrelor
por: Ma, Tingting, et al.
Publicado: (2022)

Targeting telomerase with radiolabeled inhibitors
por: Waghorn, Philip A., et al.
Publicado: (2017)

Multi-component pharmacokinetic study of prunus mume fructus extract after oral administration in rats using UPLC-MS/MS
por: Zhu, Yameng, et al.
Publicado: (2022)

A novel method to estimate the absorption rate constant for two-compartment model fitted drugs without intravenous pharmacokinetic data
por: Liu, Fan, et al.
Publicado: (2023)

Pharmacokinetics of Oral and Inhaled Terbutaline after Exercise in Trained Men
por: Dyreborg, Anders, et al.
Publicado: (2016)

Oral pharmacokinetics of sulfadiazine and sulfamonomethoxine in female Holstein milking cows
por: TAJIMA, Tsuyoshi, et al.
Publicado: (2023)

Pharmacokinetics of Oral Formulations of Gepotidacin (GSK2140944), a Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor, in Healthy Adult and Adolescent Participants
por: Barth, Aline, et al.
Publicado: (2022)

Pharmacokinetics of active compounds of a Terminalia chebula Retz. Ethanolic extract after oral administration rats using UPLC-MS/MS
por: Yao, Guangzhe, et al.
Publicado: (2023)

Recent progress in DNA methyltransferase inhibitors as anticancer agents
por: Zhang, Zhixiong, et al.
Publicado: (2022)

Pharmacokinetics of Orally Administered Oseltamivir in Healthy Obese and Nonobese Thai Subjects
por: Jittamala, Podjanee, et al.
Publicado: (2014)

Oral pharmacokinetics of acetaminophen to evaluate gastric emptying profiles of Shiba goats
por: ELBADAWY, Mohamed, et al.
Publicado: (2015)

Oral pharmacokinetics of the acidic drugs, diclofenac and sulfamonomethoxine in male Shiba goats
por: ELBADAWY, Mohamed, et al.
Publicado: (2014)

Pharmacokinetic study of single and multiple oral administration of glutamine in healthy Beagles
por: Guo, Fanxi, et al.
Publicado: (2022)

Oral absorption profiles of sulfonamides in Shiba goats: a comparison among sulfadimidine, sulfadiazine and sulfanilamide
por: ELBADAWY, Mohamed, et al.
Publicado: (2016)

The pivotal role of cholesterol absorption inhibitors in the management of dyslipidemia
por: Al-Shaer, Moutasim H, et al.
Publicado: (2004)

Modulation of Transient Receptor Potential C Channel Activity by Cholesterol
por: Gutorov, Rita, et al.
Publicado: (2019)

Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone antagonist in healthy premenopausal women
por: Xu, Yi, et al.
Publicado: (2022)

Preclinical Pharmacokinetics, Tissue Distribution, and Primary Safety Evaluation of Indo5, a Novel Selective Inhibitor of c-Met and Trks
por: Luo, Teng, et al.
Publicado: (2021)

Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis
por: Wring, Stephen A., et al.
Publicado: (2017)

First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of SPR720, a Novel Oral Bacterial DNA Gyrase (GyrB) Inhibitor for Mycobacterial Infections
por: Talley, Angela K., et al.
Publicado: (2021)

Multiparameter Optimization of Trypanocidal Cruzain Inhibitors With In Vivo Activity and Favorable Pharmacokinetics
por: Pauli, Ivani, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0c8g5me8kk7v27hje7d4f7ovne